MECHANISMS OF HEME SIGNALING IN EUKARYOTIC CELLS

真核细胞中血红素信号传导机制

基本信息

  • 批准号:
    2701708
  • 负责人:
  • 金额:
    $ 22.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-05-01 至 2002-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: This is a proposal by Li Zhang for five years of support to investigate heme signaling in yeast. The work focuses on the transcription factor HAP1, a master regulator controlling oxygen sensing and heme signaling in Saccharomyces cerevisiae. Target genes for HAP1 include cytochromes and the anaerobic repressor ROX1. The simple domain structure of HAP1 is well-characterized. There is a DNA binding and dimerization domain, belonging to the 6-cys cluster family of zinc finger proteins, a heme responsive domain with two types of repeated elements including heme binding sites, and a transcription activation domain. Key to this proposal DNA binding and activation are modulated by heme. DATA HAP1 association with a large complex (HMC) in cell extracts is also regulated by heme. Thus, Zhang's model for heme regulation proposes that in low heme HAP1 repressed by association with a large complex in the cell, possibly in a monomeric state. This HMCc has DNA binding activity. High heme levels lead to heme binding to HAP1 and dissociation of the complex. The de-repressed factor can now bind DNA as a dimer and activate transcription. Unresolved questions in this model include: what is the nature of the association of HAP1 with HMC and how does heme regulate this interaction?, which cellular factors, for example, components of HMC, are necessary for the regulation and how do these factors function? The current proposal consists of 4 specific aims. Aim 1 determines the minimal domain of HAP1 necessary for heme regulation and performs physical characterizations + heme, including a NMR structural determination. Aim 2 investigates the role of the high molecular weight complex by mutagenizing HAP1 elements proposed to be involved in HMC formation. The third aim investigates the mechanism by which HAP1 dimerization elements affect heme regulation and transcriptional activation. This aim includes both mutagenesis and tests for inter and intramolecular interactions as well as experiments designed to determine the subunit configuration of HAP1 in the HMC. The final aim employs yeast genetics, a two-hybrid screen, and biochemical approaches to identify the cellular factors involved in heme regulation.
这是一份由李章提出的为期五年的支持议案

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LI ZHANG其他文献

LI ZHANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LI ZHANG', 18)}}的其他基金

Cerebral endothelial cells derived exosomes as a therapy for cognitive impairment in aged diabetic rats
脑内皮细胞衍生的外泌体作为老年糖尿病大鼠认知障碍的治疗方法
  • 批准号:
    10601114
  • 财政年份:
    2021
  • 资助金额:
    $ 22.31万
  • 项目类别:
Cerebral endothelial cells derived exosomes as a therapy for cognitive impairment in aged diabetic rats
脑内皮细胞衍生的外泌体作为老年糖尿病大鼠认知障碍的治疗方法
  • 批准号:
    10380096
  • 财政年份:
    2021
  • 资助金额:
    $ 22.31万
  • 项目类别:
Cerebral endothelial cells derived exosomes as a therapy for cognitive impairment in aged diabetic rats
脑内皮细胞衍生的外泌体作为老年糖尿病大鼠认知障碍的治疗方法
  • 批准号:
    10211376
  • 财政年份:
    2021
  • 资助金额:
    $ 22.31万
  • 项目类别:
Targeting the Proinflammatory Activity of Integrin Mac-1 for Treatment of Atherosclerosis
靶向整合素 Mac-1 的促炎活性治疗动脉粥样硬化
  • 批准号:
    10376780
  • 财政年份:
    2019
  • 资助金额:
    $ 22.31万
  • 项目类别:
Ligand-dependent and cell type-specific functions of integrin CD11b/CD18 in multiple sclerosis
整合素 CD11b/CD18 在多发性硬化症中的配体依赖性和细胞类型特异性功能
  • 批准号:
    9892805
  • 财政年份:
    2019
  • 资助金额:
    $ 22.31万
  • 项目类别:
Ligand-dependent and cell type-specific functions of integrin CD11b/CD18 in multiple sclerosis
整合素 CD11b/CD18 在多发性硬化症中的配体依赖性和细胞类型特异性功能
  • 批准号:
    10016370
  • 财政年份:
    2019
  • 资助金额:
    $ 22.31万
  • 项目类别:
Ligand-dependent and cell type-specific functions of integrin CD11b/CD18 in multiple sclerosis
整合素 CD11b/CD18 在多发性硬化症中的配体依赖性和细胞类型特异性功能
  • 批准号:
    10660972
  • 财政年份:
    2019
  • 资助金额:
    $ 22.31万
  • 项目类别:
Ligand-dependent and cell type-specific functions of integrin CD11b/CD18 in multiple sclerosis
整合素 CD11b/CD18 在多发性硬化症中的配体依赖性和细胞类型特异性功能
  • 批准号:
    10434690
  • 财政年份:
    2019
  • 资助金额:
    $ 22.31万
  • 项目类别:
Combination treatment with Vepoloxamer and tPA for acute stroke
维泊洛沙姆和 tPA 联合治疗急性卒中
  • 批准号:
    9914137
  • 财政年份:
    2017
  • 资助金额:
    $ 22.31万
  • 项目类别:
Cerebral endothelial derived-exosomes improve cognitive function in aged diabetic rat
脑内皮源性外泌体改善老年糖尿病大鼠的认知功能
  • 批准号:
    9562948
  • 财政年份:
    2017
  • 资助金额:
    $ 22.31万
  • 项目类别:

相似海外基金

ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    6238317
  • 财政年份:
    1997
  • 资助金额:
    $ 22.31万
  • 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    5210031
  • 财政年份:
  • 资助金额:
    $ 22.31万
  • 项目类别:
CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
生物信号转导中的细胞粘附
  • 批准号:
    3732412
  • 财政年份:
  • 资助金额:
    $ 22.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了